| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:365.)
© 2006 American Heart Association, Inc.
Original Articles |
From the ADAPT Centre, Beaumont Hospital and Department of Clinical Pharmacology (E.D., N.A., P.M.C., S.M.C., E.O., A.V.S.), Royal College of Surgeons in Ireland, Dublin, Ireland; Study Coordinating Centre (L.T., Y.L., J.A.S.), Laboratory of Hypertension, Hypertension and Cardiovascular Rehabilitation Unit, Department of Cardiovascular Diseases, University of Leuven, Belgium.
Correspondence to Jan A. Staessen, Study Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, Campus Gasthuisberg, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail jan.staessen{at}med.kuleuven.be
| Abstract |
|---|
|
|
|---|
Key Words: arteries blood pressure monitoring, ambulatory epidemiology mortality
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Ambulatory Blood Pressure Measurement
From 1980 until 1984, we recorded daytime and nighttime ambulatory blood pressure by microphonic detection of the Korotkoff sounds with the prototype automated ambulatory blood pressure recorder, the Del Mar Avionics Pressurometer III (Del Mar Avionics).10 From 1985 onward, we used validated oscillometric devices (SpaceLabs 90202 or 90207, SpaceLabs11,12 or A&D TM-2430, A&D Engineering Company13) or auscultatory monitors (Spacelabs 5200,14 Profilomat, Diestronic Medical Systems15 or CH-Druck/Pressure ERKA, Diestronic Medical Systems16). We programmed the recorders to obtain blood pressure readings at 30-minute intervals throughout the whole day.9 In keeping with JNC7 guidelines,17 hypertension was a daytime (10:00 AM until 8:00 PM) ambulatory blood pressure averaging
135 mm Hg systolic or 85 mm Hg diastolic. For database management, all of the clinical data were transferred into the dabl Cardiovascular software package (dabl Ltd).
Derivation of AASI
Arterial stiffness varies nonlinearly with distending pressure: as mean arterial pressure increases, stiffness increases exponentially.18 Mean arterial pressure shows considerable diurnal variability, usually increasing with activity and declining with rest and sleep. In subjects with elastic arteries, with variation in mean arterial pressure, changes in systolic and diastolic blood pressures occur in parallel throughout the blood pressure range. In subjects with less compliant arteries, increases in the distending pressure, above a certain threshold, are associated with a greater increase in systolic pressure than diastolic pressure. In those with very stiff vessels, although systolic pressure sharply rises with each increase in mean arterial pressure, diastolic pressure may even decline.
From unedited 24-hour recordings, we computed for each participant the regression slope of diastolic on systolic blood pressure. We did not force the regression line through the origin (intercept=0),8 because during diastole when flow drops to zero, such a phenomenon does not occur for blood pressure.19 We defined AASI as 1 minus the regression slope. The stiffer the arterial tree, the closer the regression slope and AASI are to 0 and 1, respectively. Figure 1 demonstrates that for similar levels of the 24-hour ambulatory blood pressure and pulse pressure, AASI can vary considerably and, therefore, suggests that AASI might provide additional hemodynamic information.
|
Mortality Outcomes
In the absence of a unique identifier permitting ready identification of subjects in the Irish death register, vital status was ascertained by searching this computerized death register for each individual whose name also appeared in the dabl database. This process was completed in a number of steps, which have been described previously.20 Briefly, the death register was first searched for patients having both a similar name and approximate date of birth. This procedure accounted for different versions of first and surnames and/or misspelling. To overcome imprecision in the date of birth, we allowed a 2-year margin of error. If there was no match using these 2 criteria, the individual was considered to be alive. Where there was a positive match, additional confirmation of death was sought by checking addresses and records of hospitals and family doctors. This process provided definite evidence that, of the 11 291 subjects in the study cohort, 948 had died by September 30, 2002.
Because Irish death certificates state the cause of death but are not coded, the death certificate of each individual was examined, and the cause of death was coded according to the World Health Organizations International Classification of Diseases, 9th Revision. Of the 948 deaths, 566 were from cardiovascular causes; 358 were attributed to cardiac illness and 151 to stoke. Cardiac mortality included myocardial infarction (International Classification of Diseases, 9th Revision, 4100 to 4109), chronic coronary heart disease (4140 to 4149), heart failure (4280 to 4289), and sudden death (7980 to 7989). Cardiovascular mortality consisted of cardiac mortality, fatal stroke (4300 to 4389), and other vascular deaths.
Statistical Analysis
For statistical analysis, we used SAS software, version 9.1 (SAS Institute Inc). We compared means and proportions by the large sample z test and the
2-statistic, respectively. In exploratory analyses, we plotted the rates of cardiovascular mortality in quintiles of AASI or pulse pressure while standardizing for sex and age by the direct method. We calculated relative hazard ratios by multiple Cox regression with adjustment for baseline characteristics including sex, age, mean arterial pressure, body mass index, smoking, diabetes mellitus, and history of cardiovascular disease. We treated AASI and pulse pressure as continuous variables. In additional analyses, we dichotomized AASI8 and pulse pressure using the upper boundary of the 95th prediction interval for individual data points in relation to age in the Belgian, Chinese, and Irish normotensive subjects enrolled in the International Database on Ambulatory Blood Pressure Monitoring.21 Cutoff limits by decade of age ranged from 0.53 at 20 years to 0.72 at 80 years for AASI8 and from 55 mm Hg at 20 years to 60 mm Hg at 80 years for pulse pressure. We modeled the probability of the 5-year incidence of cardiovascular mortality using the Weibull distribution for time-failure data.
| Results |
|---|
|
|
|---|
|
Prediction of Cardiovascular Mortality
Over a median follow-up of 5.3 years (range, 2 days to 21.4 years), 566 cardiovascular deaths occurred. In exploratory nonparametric analyses, the sex- and age-adjusted incidence of cardiovascular mortality increased with AASI and pulse pressure (Figure 2). In Cox regression, both before and after adjustment for sex, age, mean arterial pressure, body mass index, smoking, diabetes mellitus, and previous cardiovascular disease, AASI and pulse pressure analyzed as continuous variables predicted cardiovascular mortality (Table 2). In adjusted analyses, AASI predicted fatal stroke, whereas pulse pressure predicted cardiac mortality (Table 2).
|
|
In adjusted analyses of AASI treated as a binary variable, elevated values significantly and independently predicted mortality from all of the cardiovascular causes, stroke and cardiac disease. Pulse pressure, also as a binary variable, only predicted cardiac mortality. Figure 3 shows the absolute risk of overall and cause-specific cardiovascular mortality in relation to AASI and pulse pressure.
|
Sensitivity Analyses
When in continuous analyses we additionally adjusted AASI for pulse pressure and vice versa, AASI maintained its prognostic value for stroke, whereas pulse pressure remained predictive for cardiovascular and cardiac mortality (Table 2). Furthermore, in dichotomized analyses with mutual adjustments applied as before, elevated values of AASI still predicted cardiovascular and stroke mortality, whereas a high pulse pressure lost its predictive value for the 3 fatal outcomes under study (Table 2).
Additional analyses stratified for the presence of ambulatory hypertension at baseline (Table 3) showed that AASI and pulse pressure analyzed as continuous variables predicted cardiovascular and stroke mortality in normotensive subjects and cardiovascular and cardiac mortality in hypertensive patients, respectively. In dichotomized analyses, elevated values of AASI predicted cardiovascular and stroke mortality in normotensive and hypertensive subjects, whereas an elevated pulse pressure only predicted cardiac mortality in hypertensive patients (Table 3).
|
When, in the fully adjusted models shown in Tables 2 and 3
, we substituted mean arterial pressure with systolic blood pressure as an explanatory variable, the relative hazard ratios for AASI did not materially change, whereas those for pulse pressure weakened to a nonsignificant level (data not shown). The introduction of mean 24-hour heart rate in the Cox models did not materially alter the relative hazard ratios (data not shown). The results shown in Tables 2 and 3
also remained consistent, when in the computation of AASI we applied robust regression (least-trimmed squares) or excluded influential data points (DFß>2/
n).
| Discussion |
|---|
|
|
|---|
Pulse pressure is a surrogate measure of arterial stiffness22 and an established cardiovascular risk factor.2330 The finding that in middle-aged and older patients cardiovascular prognosis worsens with higher pulse pressure is consistent in men and women,23,24,26,30 in treated and untreated hypertensive individuals,23,27,30 and in patients with a history of myocardial infarction25 or renal failure.7 Our finding that pulse pressure was more predictive at higher than lower levels of blood pressure is in line with the concept that an elevated pulse pressure already represents generalized stiffening of the large arteries and more advanced arterial disease.22,23 The observation that pulse pressure was closely related to cardiac mortality also confirms previous findings from the Framingham Heart Study. Indeed, Franklin et al29 demonstrated that in subjects <50 years of age, diastolic blood pressure was a strong predictor of coronary heart disease. Age 50 to 59 years was a transition period when systolic, diastolic, and pulse pressures were similar predictors of cardiovascular risk, whereas from 60 years on, diastolic pressure was negatively related to the risk of coronary events so that pulse pressure became a better predictor than systolic pressure. We assume that, in our study population with mean age of 54.6 years, these age-related trends29 contributed to the prognostic significance of pulse pressure.
In this current study, we have shown that AASI improves on pulse pressure in the prediction of stroke, particularly in individuals with lower average pressures. Arterial stiffness varies nonlinearly with distending pressure; as mean arterial pressure increases, stiffness increases exponentially.18 Mean 24-hour pulse pressure is an estimate of arterial stiffness at a single point on the pressure stiffness curve: it is critically dependent on the average distending pressure over the 24 hours of measurement. By contrast, AASI rests on the concepts that average distending pressure varies during the day and that the relation between diastolic and systolic blood pressure, with this changing distending pressure, largely depends on the structural and functional characteristics of the large arteries.31 AASI consequently provides insight into the position of the pressure stiffness curve and, therefore, into intrinsic wall stiffness. This feature may importantly contribute to the improved prognostication of stroke by AASI in ambulatory normotensive subjects and prompts speculation that AASI might predict outcome in patients with well-controlled hypertension. The companion article8 supports this contention that AASI, but not pulse pressure, correlates with systolic augmentation <40 years of age, raising the possibility that AASI might be a more sensitive indicator of arterial stiffening in younger patients. Moreover, particularly in younger subjects, pulse pressure measured at the brachial artery is higher than the central pulse pressure,19 which is an important determinant of cardiac complications. Indeed, lowered diastolic pressure in the ascending aorta can impair coronary blood flow and predispose to myocardial ischemia, whereas increased central systolic pressure augments cardiac work and can lead to heart failure.19,30 Other prospective studies of both normotensive and hypertensive subjects are required to test the hypothesis that the predictive value of AASI and pulse pressure differ according to age, level of central arterial pressure, and target organ damage.
We propose AASI as a novel index of arterial stiffness. Outcome data support the predictive value of other indirect measures of arterial stiffness.17,2330 However, with the exception of pulse pressure,2330 these measures are not presently readily available in clinical practice. Our new measure of arterial stiffness may be easily and directly derived from ambulatory blood pressure monitoring, which is implemented in most hospitals and a growing number of family practices. AASI is not operator dependent. Most hypertension guidelines already recommend the use of ambulatory blood pressure monitoring in patients referred with elevated clinic blood pressures.17 The present study, therefore, adds to evidence already supporting the use of ambulatory blood pressure monitoring in routine clinical practice.9,3235
Some limitations of our study should be addressed. We did not collect nonfatal health outcomes. Also, given the process used to ascertain fatal outcomes, some deaths may not have been recorded because of emigration or marriage. Ambulatory blood pressure monitoring was performed at baseline off treatment using different validated1016 devices. More than 90% of the recordings were obtained with oscillometric SpaceLabs monitors.11,12 Obviously those patients found to be truly hypertensive were offered blood pressurelowering pharmacological treatment. However, the aforementioned confounders would have led to an underestimation rather than an overestimation of the observed associations. Other conditions could lead to an erroneous estimate of AASI, such as the variable stroke volume in patients with atrial fibrillation. Yet, AASI did not differ between 20 individuals with atrial fibrillation and 20 age- and sex-matched individuals in sinus rhythm (data not shown). A limited range of systolic blood pressure values throughout the 24 hours would tend to flatten the regression slope and erroneously increase AASI. However, in our study population, the systolic blood pressure range tended to increase across the fifths of the AASI distribution rather than the converse. Outlying data points can greatly influence linear regression, but our results remained consistent when we applied robust regression or discarded outliers in the derivation of AASI.
Perspectives
We studied AASI as a novel index of arterial stiffness, which reflects the diurnal variation in the relation between the diastolic and systolic inflection points of the arterial pressure wave. We validated AASI as a prognostic indicator of total and cause-specific cardiovascular mortality. Its predictive value may complement that provided by pulse pressure in that it appears to be a stronger predictor of stroke mortality, especially in normotensive subjects. Pending additional physiological and clinical8 studies and confirmation of the present outcome results in other cohorts, AASI might add to the stratification of risk based on ambulatory blood pressure monitoring.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 19, 2005; first decision June 13, 2005; accepted October 25, 2005.
| References |
|---|
|
|
|---|
sowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000; 355: 865872.[CrossRef][Medline]
[Order article via Infotrieve]This article has been cited by other articles:
![]() |
D. Nyhan and D. E. Berkowitz Perioperative Blood Pressure Management: Does Central Vascular Stiffness Matter? Anesth. Analg., October 1, 2008; 107(4): 1103 - 1106. [Full Text] [PDF] |
||||
![]() |
B. Williams The year in hypertension. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF] |
||||
![]() |
D. G. Dechering, A. Adiyaman, M. van der Steen, and T. Thien Interstudy Variability in the Ambulatory Arterial Stiffness Index Hypertension, September 1, 2007; 50(3): e65 - e65. [Full Text] [PDF] |
||||
![]() |
E. O'Brien Is the Case for ABPM as a Routine Investigation in Clinical Practice Not Overwhelming? Hypertension, August 1, 2007; 50(2): 284 - 286. [Full Text] [PDF] |
||||
![]() |
G. Schillaci, G. Parati, M. Pirro, G. Pucci, M. R. Mannarino, L. Sperandini, and E. Mannarino Ambulatory Arterial Stiffness Index Is Not a Specific Marker of Reduced Arterial Compliance Hypertension, May 1, 2007; 49(5): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kikuya, J. A. Staessen, T. Ohkubo, L. Thijs, H. Metoki, K. Asayama, T. Obara, R. Inoue, Y. Li, E. Dolan, et al. Ambulatory Arterial Stiffness Index and 24-Hour Ambulatory Pulse Pressure as Predictors of Mortality in Ohasama, Japan Stroke, April 1, 2007; 38(4): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Westerhof, J.-W. Lankhaar, and B. E. Westerhof Letter to the Editor: Ambulatory Arterial Stiffness Index Is Not a Stiffness Parameter But a Ventriculo-Arterial Coupling Factor Hypertension, February 1, 2007; 49(2): e7 - e7. [Full Text] [PDF] |
||||
![]() |
Y. Li, J.-G. Wang, E. Dolan, E. O'Brien, T. W. Hansen, H. Ibsen, M. Kikuya, Y. Imai, T. Richart, L. Thijs, et al. Letter to the Editor: Response to Arterial Stiffness Index Is Not a Stiffness Parameter But a Ventriculo-Arterial Coupling Factor Hypertension, February 1, 2007; 49(2): e8 - e9. [Full Text] [PDF] |
||||
![]() |
B. Gavish Correlating Ambulatory Blood Pressure Measurements With Arterial Stiffness: A Conceptual Inconsistency? Hypertension, December 1, 2006; 48(6): e108 - e108. [Full Text] [PDF] |
||||
![]() |
Y. Li, J.-G. Wang, E. Dolan, E. O'Brien, L. Thijs, T. Nawrot, and J. A. Staessen Response to Correlating Ambulatory Blood Pressure Measurements With Arterial Stiffness: A Conceptual Inconsistency Hypertension, December 1, 2006; 48(6): e109 - e109. [Full Text] [PDF] |
||||
![]() |
B. Williams The Year in Hypertension J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1698 - 1711. [Full Text] [PDF] |
||||
![]() |
E. O'Brien Ambulatory Blood Pressure Measurement: A Trove of Hidden Gems? Hypertension, September 1, 2006; 48(3): 364 - 365. [Full Text] [PDF] |
||||
![]() |
G. Leoncini, E. Ratto, F. Viazzi, V. Vaccaro, A. Parodi, V. Falqui, N. Conti, C. Tomolillo, G. Deferrari, and R. Pontremoli Increased Ambulatory Arterial Stiffness Index Is Associated With Target Organ Damage in Primary Hypertension Hypertension, September 1, 2006; 48(3): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, L. Thijs, and J. A. Staessen Blood Pressure Lowering for Primary and Secondary Prevention of Stroke Hypertension, August 1, 2006; 48(2): 187 - 195. [Full Text] [PDF] |
||||
![]() |
Y. Li, J.-G. Wang, E. Dolan, P.-J. Gao, H.-F. Guo, T. Nawrot, A. V. Stanton, D.-L. Zhu, E. O'Brien, and J. A. Staessen Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring Hypertension, March 1, 2006; 47(3): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Laurent Surrogate Measures of Arterial Stiffness: Do They Have Additive Predictive Value or Are They Only Surrogates of a Surrogate? Hypertension, March 1, 2006; 47(3): 325 - 326. [Full Text] [PDF] |
||||
![]() |
A. Benetos and P. Lacolley From 24-Hour Blood Pressure Measurements to Arterial Stiffness: A Valid Short Cut? Hypertension, March 1, 2006; 47(3): 327 - 328. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||